| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 745 |
| 1 | PEMBROLIZUMAB | 686 |
| 2 | IPILIMUMAB | 385 |
| 3 | CARBOPLATIN | 375 |
| 4 | PACLITAXEL | 238 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 230 |
| 6 | PEMETREXED DISODIUM | 200 |
| 7 | PEMETREXED | 156 |
| 8 | DURVALUMAB | 128 |
| 9 | ATEZOLIZUMAB | 108 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ENSITRELVIR | 1 | 0.0556 |
| 1 | SUNVOZERTINIB | 1 | 0.0244 |
| 2 | PENPULIMAB | 1 | 0.0102 |
| 3 | PAPAVERINE HYDROCHLORIDE | 1 | 0.0098 |
| 4 | IPILIMUMAB | 385 | 0.0088 |
| 5 | ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE | 1 | 0.0086 |
| 6 | DOSTARLIMAB | 20 | 0.0080 |
| 7 | LEVAMLODIPINE | 1 | 0.0080 |
| 8 | NIVOLUMAB | 745 | 0.0076 |
| 9 | TETRACAINE HYDROCHLORIDE | 1 | 0.0075 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1521 | 0.0154 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 404 | 0.0084 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 129 | 0.0060 |
| 3 | Lymphocyte Growth Factor [EPC] | 7 | 0.0055 |
| 4 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 5 | Platinum-based Drug [EPC] | 506 | 0.0018 |
| 6 | Microtubule Inhibitor [EPC] | 255 | 0.0015 |
| 7 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 11 | 0.0013 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |